Back to Studies

P1026S / PK in Pregnancy

Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and
Postpartum

Study Status

Closed to Follow Up

Locality

US & Non-US

DAIDS Number

10040

IND Number

64,535

Clinical Trials Link

Summary

P1026s is a Phase IV, prospective pharmacokinetic (PK) study of selected ARV drugs currently used in the clinical care of HIV-infected pregnant women during pregnancy and postpartum.  This study is designed to evaluate the following: the pharmacokinetics of antiretroviral medicines when used alone or co-administered with tuberculosis medicines during pregnancy; the pharmacokinetic parameters of lopinavir/ritonavir and atazanavir/ritonavir/tenofovir in women postpartum before and after starting hormonal contraceptives; and the concentrations of ethinyl estradiol, etonogestrel and other progestins in women using hormonal contraceptives and protease inhibitors.

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...